TITLE

Analysis of Nevirapine (NVP) Resistance in Ugandan Infants Who Were HIV Infected Despite Receiving Single-Dose (SD) NVP versus SD NVP Plus Daily NVP Up to 6 Weeks of Age to Prevent HIV Vertical Transmission

AUTHOR(S)
Church, Jessica D.; Omer, Saad B.; Guay, Laura A.; Wei Huang; Lidstrom, Jessica; Musoke, Philippa; Mmiro, Francis; Jackson, J. Brooks; Eshleman, Susan H.
PUB. DATE
October 2008
SOURCE
Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1075
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Single-dose nevirapine (SD NVP) at birth plus NVP prophylaxis for the infant up to 6 weeks of age is superior to SDNVP alone for prevention of vertical transmission of human immunodeficiency virus (HIV) through breastfeeding. We analyzed NVP resistance in HIV-infected Ugandan infants who received either SD NVP or extended NVP prophylaxis. Methods. We tested plasma HIV by using a genotyping assay (ViroSeq; Celera Diagnostics), a phenotypic resistance assay (PhenoSense; Monogram Biosciences), and sensitive point mutation assay (LigAmp, for K103N, Y181C, and G190A). Results. When infants were 6 weeks old, ViroSeq detected NVP resistance in a higher proportion of infants in the extended NVP arm than in the SD NVP arm (21 of 25 [84%] vs. 12 of 24 [50%]; P = .01). Similar results were obtained with LigAmp and PhenoSense. In both study arms, infants who were HIV infected at birth frequently had NVP resistance detected. In contrast, infants in the extended NVP arm who were HIV infected after birth were more likely to have resistance detected at 6 weeks, compared with infants in the SD NVP arm. The use of extended NVP prophylaxis was also associated with detection of NVP resistance by ViroSeq at 6 months (7 of 7 [100%] infants in the extended NVP arm had resistance detected, compared with 1 of 6 [16.7%] infants in the SD NVP arm; P = .005). Conclusions. The use of extended NVP prophylaxis was associated with increased selection for and persistence of NVP resistance in HIV-infected Ugandan infants.
ACCESSION #
34372506

 

Related Articles

  • Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. Ciaranello, Andrea L.; Ji-Eun Park; Ramirez-Avila, Lynn; Freedberg, Kenneth A.; Walensky, Rochelle P.; Leroy, Valeriane // BMC Medicine;2011, Vol. 9 Issue 1, p59 

    Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-child transmission (PMTCT) services, but has been challenging to implement in resource-limited settings....

  • HIV/AIDS knowledge in detention in Hunan province, China. Weidong Zhang; Xinya Wang; Xi Chen; Fan Lv // BMC Public Health;2010, Vol. 10 Issue 1, p221 

    Background: Injection drug use (IDU) is one of the major modes of HIV transmission in China. Drug use is illegal in China, all identified drug users are registered by Public Security Bureau, and most were sent to detention; most detainees engaged in high risk behaviours. In order to well...

  • Trends in HIV & syphilis prevalence and correlates of HIV infection: results from cross-sectional surveys among women attending ante-natal clinics in Northern Tanzania. Kumogola, Yusufu; Slaymaker, Emma; Zaba, Basia; Mngara, Julius; Isingo, Raphael; Changalucha, John; Mwidunda, Patrick; Kimaro, Daniel; Urassa, Mark // BMC Public Health;2010, Vol. 10 Issue 1, p553 

    Background: Sentinel surveillance for HIV in ante-natal clinics (ANC) remains the primary method for collecting timely trend data on HIV prevalence in most of sub-Saharan Africa. We describe prevalence of HIV and syphilis infection and trends over time in HIV prevalence among women attending...

  • AIDS Drug Assistance Programs in the Era of Routine HIV Testing. Bassett, Ingrid V.; Farel, Claire; Szmuilowicz, Emily D.; Walensky, Rochelle P. // Clinical Infectious Diseases;9/1/2008, Vol. 47 Issue 5, p695 

    AIDS [Acquired Immunodeficiency Syndrome] Drug Assistance Programs, operating within the larger Ryan White Program, are state-based, discretionary programs that provide a drug "safety net" for low-income and uninsured individuals infected with human immunodeficiency virus (HIV). Although the...

  • Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. Doherty, Tanya; Chopra, Mickey; Nsibande, Duduzile; Mngoma, Dudu // BMC Public Health;2009, Vol. 9 Issue 1, p406 

    Background: Despite several years of implementation, prevention of mother-to-child transmission (PMTCT) programmes in many resource poor settings are failing to reach the majority of HIV positive women. We report on a data driven participatory quality improvement intervention implemented in a...

  • Prevention of mother-to-child transmission of HIV infection: Views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi. O'Gorman, Deirdre A.; Nyirenda, Lot J.; Theobald, Sally J. // BMC Public Health;2010, Vol. 10 Issue 1, p354 

    Background: In 2006 the World Health Organization described the status of prevention of mother to child transmission (PMTCT) service implementation as unacceptable, with an urgent need for a renewed public health approach to improve access. For PMTCT to be effective it needs to be accessible,...

  • Risk factors for HIV infection in Males who have Sex with Males (MSM) in Bangladesh. Chan, Philip A.; Khan, Omar A. // BMC Public Health;2007, Vol. 7 Issue 1, p153 

    Background: Recent surveillance data from Bangladesh indicate rising HIV infection among intravenous drug users (IDU) in the country. We suggest a likely association between HIV risk factors in this group and other groups, such as males who have sex with males (MSM). Methods: Data on MSM in...

  • Nevirapine Resistance in Women and Infants after First versus Repeated Use of Single-Dose Nevirapine for Prevention of HIV-1 Vertical Transmission. Flys, Tamara S.; McConnell, Michelle S.; Matovu, Flavia; Church, Jessica D.; Bagenda, Danstan; Khaki, Leila; Bakaki, Paul; Thigpen, Michael C.; Eure, Chineta; Fowler, Mary Glenn; Eshleman, Susan H. // Journal of Infectious Diseases;8/15/2008, Vol. 198 Issue 4, p465 

    Single-dose (SD) nevirapine (NVP) significantly reduces mother-to-child transmission of human immunodeficiency virus (HIV). We analyzed NVP resistance after receipt of SD NVP in 57 previously SD NVP-naive women, in 34 SD NVP-experienced women, and in 17 HIV-infected infants. The proportion of...

  • FDA Approves New HIV Integrase Inhibitor, Merck Says.  // Clinical Infectious Diseases;12/15/2007, Vol. 45 Issue 12, piv 

    The article reports that a new treatment for HIV infection called Raltegravir made by Merck & Co. Inc. has been approved by U.S. Food and Drug Administration. This is the first integrase inhibitor aimed at preventing replication of the virus. This will be sold under the trade name Isentress. Dr....

  • HIV Infection Presenting in Older Children and Adolescents: A Case Series from Harare, Zimbabwe. Ferrand, Rashida A.; Luethy, Ruedi; Bwakura, Filda; Mujuru, Hilda; Miller, Robert F.; Corbett, Elizabeth L. // Clinical Infectious Diseases;3/15/2007, Vol. 44 Issue 6, p874 

    Background. Symptomatic human immunodeficiency virus (HIV) infection during late childhood and adolescence may be an emerging problem in southern Africa, but it is one that is poorly described. We investigated social and clinical features in patients of this age group presenting to a HIV...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics